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I.

Introduction

What is Cancer?
Cancer is both an increasingly prevalent and incredibly complex group of diseases. By
definition, cancer involves the uncontrollable growth and spread of mutated cells to other parts
of the body.¹ The American Cancer Society projected that 606,520 people would die from cancer
and 1.8 million new cancer cases would emerge in 2020.² Complications from cancer are the
second leading cause of death in the United States, only behind heart disease.³ These numbers
demonstrate that despite ongoing efforts to curb different forms of cancer and the deaths caused
by them, cancer remains a leading cause of disease and premature death.
The average life expectancy of humans has increased dramatically over the years, largely
due to a decrease in deaths caused by infectious disease. Yet, the number of cancer cases have
also increased. With people living longer, there is more time for DNA mutations to accumulate
and cause uncontrolled growth, as seen in cancer cases.⁴ Despite decades of study, the incidence
of many cancers is still on the rise, and a “silver bullet” treatment option still eludes us. The
inability to develop an effective treatment is due to the fact that cancer is not a single disease, but
a group of diseases classified together due to their shared characteristics of uncontrolled cell
growth and increased rate of DNA mutations. This makes treatment difficult, as each type of
cancer develops from a complex set of circumstances, and the fast mutation rate of cancerous
cells allows for many treatments to be rendered ineffective due to the development of resistance.
Identifying risk factors associated with specific types of cancers can help elucidate the
mechanisms that lead to cancer, and thus detail how distinct DNA mutations begin to arise.
Furthermore, due to the complex changes that can occur after the initial stages of cancer
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development, it can be most beneficial to attack cancer at its source, which is often exposure to
carcinogenic, or cancer-causing, factors. This thesis will explore cancer in the context of obesity
and high fat diet consumption, both of which can alter the body’s environment and make it ideal
for cancer development. It will also approach obesity-related cancer, specifically colon cancer, in
the context of different physiological processes to gain a greater understanding of their specific
impact on the disease. Before the intricacies of cancer are introduced, however, it is important to
understand what disease is and how the field of pathology is constantly changing to
accommodate the development of new diseases.

Disease
Disease is “any harmful deviation from the normal structural or functional state of an
organism, generally associated with certain signs and symptoms and differing in nature from
physical injury.⁵” This broad definition means that disease can include a variety of conditions,
such as the common cold, diabetes, depression, and cancer. Disease is all around us in a myriad
of forms with seemingly endless treatments and solutions. Because every person is different
biologically and has different social situations the same diseases can even present differently
between two individuals within a population.
The common cold, for example, can be caused by hundreds of related viruses, and the
symptoms may vary in type and severity from person to person.⁶ Because of this, there is a need
for a variety of treatment options to care for each person’s needs. Some diseases have relatively
straightforward solutions, such as prescribing a medication to combat a virus or bacteria. For
example, in the case of a strep throat, pathogenic species of streptococcus bacteria are present in
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the throat where they do not normally belong in large amounts. To combat this unwanted
bacterial growth, antibiotics such as amoxicillin can be prescribed.⁷
Many diseases cannot be completely cured, so treatments must focus more heavily on the
alleviation of symptoms. In the case of an STI such as Herpes Simplex Virus (HSV,) there is
currently no cure that can remove the virus completely. This means that the treatments for this
ailment have to target either the spread of the virus or the symptoms associated with it. A popular
treatment is acyclovir, which is an ointment that can be used to stop the multiplication of the
virus; over-the-counter creams may be also used to alleviate any itching or pain that often
accompany the presence of HSV.⁸ These solutions do not work for every case of HPV, however,
and some patients may have a harder time curbing the effects of the virus. Because diseases can
present differently in different people’s bodies, there is an ongoing need to explore diseases and
their treatments. This is accomplished in the field of pathology.

Pathology
The world of pathology, or the study of diseases, is constantly changing with the advent
of new diseases and new versions of existing diseases. Pathology involves determining the cause
of the disease, its etiology, and understanding the mechanisms through which a disease develops,
its pathogenesis.⁵ The morphological changes and functional consequences of those changes are
also important in identifying a disease and choosing the most effective treatment options. These
aspects of pathology are constantly being researched, revised, and rewritten to help keep society
as healthy as possible. Even despite the importance of this field, pathological research is a highly
competitive field because funding can be expensive and tedious. Often, researchers will go
through a peer review process to ensure that their research is worthwhile and reproducible by
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others. The projects that survive this process are deemed fit to receive funding, usually projects
that are “more significant” in their importance and application to society.⁹
Despite the efforts aimed at preventing and treating disease, some form of disease will
always persist within our population, whether it be an infectious substance, such as COVID-19
or a person’s own body malfunctioning, like in cancer. Cancer is a group of diseases that is
generally not well understood in society. In order to understand how cancer develops, it is
important to know how cells function normally and what causes a cell’s DNA to mutate. Because
DNA is essential for proper cellular function and organism life, mutations in a person’s DNA can
accumulate and “selfishly” cause death of the person.

Cells
Cells are the building blocks of life, and every living thing is composed of one or more
cells.¹⁰ While there are many different organisms that have cells with different forms and
functions, the focus of this thesis will be the cells that make up human bodies. Humans are
composed of trillions of cells.¹¹ By virtue of our multicellular composition, our bodies both
permit and rely on cell specialization, wherein different cells are able to adopt specialized
functionality in the body. There are over 200 different types of cells in the human body, each
contributing to the overall composition of organs and their functions.¹⁰ In order for these organs
to function as they should, the cells that make them up need to “behave” in the right way given
the context in which they exist.
Under normal conditions in an adult, cells copy themselves in a process called cell
division when the body needs to grow, respond to an environmental cue, or replace worn out
cells. For many tissues, when cells become old or damaged, they die, and new cells replace
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them.⁵ Cell death often occurs through a precise pathway known as apoptosis, which will be
discussed in more detail later in the literature review. The body carefully and regularly completes
this process, and some cells are replenished more than others based on their position and function
within the body. However, this cell division can malfunction and either allow cells to multiply at
a rapid, abnormal rate or remain “immortal” long after their intended lifespan. Both of these
malfunctions can lead to the development of uncontrolled cell growth that is a hallmark of
cancer.

DNA Damage
The molecule that carries genetic information and instructions for cellular processes is
called deoxyribonucleic acid, or DNA. DNA is the most fundamental part of a person’s chemical
makeup, and is stored in the nucleus of the cell. DNA can be transcribed and translated into
usable molecules for the body: proteins.¹⁰ Therefore, when a cell’s DNA is damaged or altered,
depending on where the changes occur in the DNA’s structure, the cell may not function
normally and the structural integrity may be compromised. This incites some response to the
inflicted DNA damage which will determine the fate of a cell, as seen in Figure 1.

Figure 1: DNA Damage and Possible Responses¹²
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The figure above illustrates a few agents that cause DNA damage, as well as several
outcomes that result from DNA damage. DNA damage can be repaired through several
mechanisms, as seen in the box at the center of the figure, but repairs are not always possible if
there is persistent or accumulated DNA damage. If DNA repair is not possible, cells will likely
be signaled to undergo apoptosis, or programmed cell death, to prevent damage from causing
harm or being passed on.¹³ An additional response to DNA damage that is not pictured is the
mutation of a particular strand of DNA.
DNA mutations are changes in the sequence of base pairs and often the molecular
products.¹³ Some common DNA mutations seen in cancer are in proto-oncogenes.¹⁴ These genes
normally help cells to grow at normal rates; when mutated to form oncogenes, which are
permanently activated forms of proto-oncogenes, cells are allowed to grow out of control.
Mutations in tumor suppressor genes can also contribute to cancer development. These kinds of
genes normally slow cell replication and repair any DNA damage before mutations can occur;
however, when these genes are mutated, cell division can occur quickly and allow for rapid cell
proliferation, or production.¹⁴ Both of these DNA mutations occur as a result of accumulated
DNA damage that was unable to be repaired or in cells unable to initiate programmed cell death
once DNA damage accumulated past the point of repair.

Programmed Cell Death
DNA damage is actually quite common, due to the constant exposure to damaging agents
inside and outside of cells. In healthy cells, mechanisms exist to curb possible consequences of
damaged DNA by removing potentially harmful cells through regulated cell death, otherwise
known as apoptosis (Figure 2) Apoptosis is an incredibly necessary process and allows older
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cells to be recycled in a neater fashion than other cell deaths, such as necrosis, which involves
the lysing of cells and the leaking out of their components.¹

Figure 2: The Process of Apoptosis through Extrinsic and Intrinsic Pathways¹⁵

Depending on which apoptotic pathway is activated, either extrinsic (from an external
signal) or intrinsic (relying on a message from inside the cell,) apoptosis can follow one of two
signaling cascades, both of which result in apoptotic action and the death of cells. Each relies on
a signal, whether it be external or from somewhere inside the cell, to activate procaspases and
activate them to become caspases. Procaspases are the inactive form of caspases, which are
enzymes that initiate programmed cell death due to their protease activity (ability to break down
protein molecules.¹)
Once the first procaspase is activated, apoptosis follows a series of caspase activations,
which activate and often phosphorylate the next molecule in the pathway. Each step in the
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pathway ultimately leads to the breakdown of the cell’s genome and organelles, all of which are
packaged into small vesicles to be shipped out of the cell and recycled by immune cells that
engulf them.¹ Though DNA damage is common within cells, cancer only develops if there is a
specific kind of mutation or an accumulation of DNA mutations.¹⁶ This usually occurs when a
cell is exposed to cancer-causing agents called carcinogens over a long period of time, though it
is possible in shorter spans if a catastrophic event occurs.
This explains why many forms of cancer are more common for older people than children
and young adults. However, there are exceptions to this trend. For example, some people are
born with mutations that predispose them to developing cancer at a young age. These genetic
factors are important to keep in mind, but will not be the focus of this literature review. Though a
person’s age plays a role in their susceptibility to cancer, there are certain behaviors, known as
risk factors, that dramatically increase a person’s likelihood of developing certain kinds of
cancer.

Cancer Risk Factors
Risk factors are conditions or behaviors that can expose a cell to carcinogenic factors,
which lead to the development of different forms of cancer.¹⁷ This means that if there is a
reduction of risk factors for a given type of cancer, there should also be a reduction of that
cancer’s incidence in society. While the evidence for a risk factor’s influence on the development
of a specific type of cancer may be clear, individuals do not always heed the warnings to stop the
behaviors that have been demonstrated to lead to cancer. This, and the variety of reasons that
underlie the hesitancy to change, can make it difficult to reduce cancer incidences.
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One example of a risk factor associated with a particular cancer is smoking. Smoking is a
behavior that skyrocketed in popularity in the 1930s after the end of the Prohibition.¹⁸ Seemingly
harmless at the time, the habit was broadly adopted. It was not until decades later that research
confirmed that smoking drastically increased the risk of an individual developing lung cancer. In
an attempt to reduce the incidence of people taking up smoking, the United States government
switched smoking ads from promoting tobacco use to warning about the dangers associated with
smoking. However, such warnings often have little to no effect on those that are already addicted
to smoking.⁴ Additional complications such as powerful lobbies and misinformation have also
complicated efforts to curb smoking and thus reduce the incidence of lung cancer. Finally,
although many people have stopped smoking as a result of increased awareness, those who have
smoked for long periods of time are still at high risk of developing lung cancer since the damage
to their DNA had already been done by the carcinogens present in cigarettes.¹⁷
A similar risk for cancer is exemplified by sun exposure, which is a known risk factor for
skin cancer. The trend to be tan was extremely popular in the 1980s to the early 1990s, and there
was little understanding at the time how much UV radiation could be absorbed from prolonged
sun exposure.⁴ Because of this, people were more apt to spend long periods of time outside
without sun protection and often experienced fairly severe sunburns, which could have initiated
skin cancer development. There is greater awareness now regarding the dangers of tanning and
UV radiation as a carcinogen. Additionally, there is clearer communication about dangers of sun
exposure without sunscreen or other sun protection and warnings of the skin cancer risk that can
occur if precautionary measures are not taken. However, some people do not heed the warnings
to limit their UV exposure or wear sunscreen because their desire and pressure to adhere to
current social norms of beauty compel them to continue dangerous behaviors.¹⁹
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As a final example of behavior-related risk factors, the high amount of fat content in
some people’s diets has also been linked to the development of cancer. Over time, aided in part
by a shift in societal roles of men and women as well as economic pressures, many countries
around the world now rely heavily on fast food chains to meet their dietary needs. These kinds of
foods are quick, convenient, and fairly inexpensive. The United States is currently ranked 12th in
the world for highest prevalence of obesity, both due to high fat diets and reduced physical
activity.²⁰ There is ongoing research on the benefits and drawbacks to certain kinds of diets, but
high fat diets and obesity are now considered a category of carcinogen, contributing to cancers
such as uterine and colorectal cancer, among others.¹⁷ Despite the data that points to high fat
diets being a risk for some forms of cancer, many people have not reduced their high-fat intake
for a variety of reasons, including convenience, cost, taste, and lack of accessibility to lower fat
options. Reducing the risk that an individual will develop cancer is the most logical way to
decrease cancer occurrence in society; however, if preventative measures are not possible in the
attempt to curb cancer, there need to be treatments in place to combat the growing disease.

Cancer Treatments
The realm of cancer treatment is constantly changing due to advancements made possible
by scientific research. Because of this, current cancer treatments have increased efficacy against
many types of cancers as well as reduced side-effects.⁴ It is important to note that there is not one
single cure for cancer, since every kind of cancer acts through a different mechanism within the
body. Each treatment has distinct effectiveness at targeting different forms of cancer, so
individualized plans of action are necessary when treating each person’s cancer. Many people
also utilize multiple different treatments to attack their form of cancer more effectively. Some of
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the most common cancer treatment categories include chemotherapy, radiation, and
immunotherapy, which will be discussed later in more detail.

Thesis Focus
This thesis is a literature review exploring how high-fat diets and obesity are linked
to colon cancer by analyzing endocrine signaling, angiogenesis, and immune signaling.
Understanding colon cancer in the context of these physiological processes can offer some
insight into the complex nature of this obesity-linked cancer and also open an avenue through
which to explore more effective preventative measures. In order to do this, however, an extensive
background on the history of cancer and its risk factors must first be established. This is
necessary to understand before exploring how high fat intake and obesity changes a person’s
body microenvironment and makes it more susceptible to colon cancer development.
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II.

Background

As stated previously, cancer is one of the oldest and most persistent maladies. This group
of diseases has been plaguing human populations for as long as there has been a written record of
medicine, and likely even before then. Cancer is so challenging to combat because it can appear
in a myriad of different forms, each arising via a different mechanism and requiring its own
specifically-tailored treatment. It remains an unresolved disease, but the field of cancer research
has come incredibly far from cancer’s first influences on society and researchers and scientists
continue to make surprising discoveries daily . In this section, the history of cancer research will
be detailed in order to give a clearer picture of what cancer research looked like throughout
history and how our understanding and treatment of cancer has progressed.

The Four Humors
One of the earliest medical explanations for disease was the theory of the four humors.
The four humors were recognized to be blood, phlegm, yellow bile, and black bile. This theory
was formulated and put into practice by a group known as the Hippocratics in Greece in the 4th
and 3rd centuries BC, and it persisted for the next 2000 years.²¹ It was believed that an imbalance
of any of the 4 humors would cause different ailments within the body. If there was an excess of
blood, for example, the person may experience abnormal bleeding such as a nosebleed. If there
was an excess of phlegm, usually in the winter season, a patient could be deemed phlegmatic,
meaning they experienced respiratory or chest problems.²² Black bile was the only humor that
wasn’t incredibly visible within the body, so it was attributed to the abnormal masses we now
understand to be cancer.²³
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Because the four humors were the basis on which medical practice was based, they were
the subject of any treatment of physicians until about the 16th century AD.²² Generally, it was
common to target the humor that was present in excess and restore the body to equilibrium, using
practices such as purging, catharsis, diuresis, and bloodletting.²⁴ Bloodletting was a common
treatment of disease in the first century AD, but it rose in popularity when Galen of Pergamum
deemed blood to be the most abundant of the humors.²⁴ Galen had a large influence on the field
of science, both during his lifetime and the many years after. As far as cancer treatment was
concerned, Galen held the belief that once diagnosed, cancer was untreatable and incurable. This
belief was held for many years, even after Galen’s death. Following this, limited progress was
made in understanding for centuries, until the blastema theory was introduced.

Blastema Theory
In 1838, Johannes Muller postulated that cancer was made up of cells, not lymph or the
“humor” of black bile.²³ Muller believed that the cancerous “blastema” was formed from a
mysterious, granular substance that came from the blood and could work its way between normal
tissues. This substance was not made from normal cells, as healthy tissues were, and were
thought to burst and expel cancer into the body.²⁵ Muller’s theory helped to prove that blood was
involved in the development of cancer, rather than black bile, but was not necessarily the cause
of cancer. The material found in the blood that formed the blastema was thought to be abnormal
before it was deposited in the body’s tissues, but the mechanism that lead to this abnormality was
unknown at the time.²⁵
The discovery that cancer was comprised of cells opened up a new avenue through which
to explore cancer cells using microscopy. Being able to observe abnormal cancer cells and
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compare them to their normal counterparts was revolutionary in the field of cancer research, as
scientists could study their differences and visualize how they acted under different
circumstances. One of Muller’s employees, Theodor Schwann, also established the cell theory
around this time, demonstrating that humans and animals were composed of microscopic cells.
Both of these discoveries helped to advance the field of cancer research and establish abnormal
cells as the cause of cancerous masses within the body.²⁶ Both men and their other colleagues
understood that cancer was not caused by the humors within the body and should not be treated
by “balancing the four humors;” however, the method by which cancer could be treated was still
unclear. Scientists were still searching for the best way to treat and cure cancer, whether that be
using chemicals in the form of drugs or removing the diseased tissues altogether through surgery.

Radical Surgery
Surgery was not the treatment of choice in the early days of cancer research, as it was
often risky and complicated. Early surgical practices often resulted in excessive or uncontrolled
bleeding or infection of the surgical site. Because there were no standard antibiotic medications
and aseptic surgery had not yet been widely adopted, infection could very easily spread
throughout the body via the bloodstream and lead to death.⁴ There was a high risk associated
with surgical removal of tumors at this time, and oncological surgery was a practice without a
standard practice of care. However, as surgery became a more viable option for cancer treatment
due to increasing safety in practice, William Steward Halstead became one of the most
influential surgeons in the 20th century and beyond.²⁷
Halstead entered the realm of science and surgery at a time when practices were
transitioning. Doctors began switching from using bloodletting, leaching, and purging – which
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had been used regularly in the previous centuries– to operating on patients more frequently in an
attempt to remove whatever was ailing them.⁴ Halstead is credited today with the shaping of
surgical practice at Johns Hopkins during his lifetime and perfecting the radical mastectomy as a
form of treatment for breast cancer.²⁸ He understood that there was a need to improve treatments
for different kinds of cancer and used his knowledge of anatomy to help ensure that cancer did
not return once a tumor was removed. His approach, however, was far different from that of his
predecessors, and his techniques were what gained him so much renown within the scientific
community.
Other physicians who had been performing minor surgeries or lumpectomies in their
patients almost always saw a relapse of breast cancer soon after the surgery was performed.
Halstead inferred that this meant there was most certainly cancerous tissue being left behind in
these surgical procedures. He decided, then, that the only way to ensure cancer was fully
eliminated was to remove the surrounding tissues, such as muscles in the chest, shoulders and
arms, as well as nearby lymph nodes and sometimes even parts of the rib cage.²⁷ While he had
success in the form of patient remissions many of the times he performed such surgeries, he left
his patients horribly disfigured and in chronic pain from the parts they lost in the process.
As a whole, surgical practice then was very different than it is now. Previously, there had
been little to no sanitization or sterilization of instruments to be used in surgical procedures. At
this time in history, antiseptics such as phenol were being developed and introduced; Halstead
also worked to prioritize using rubber gloves and sanitizing instruments before using them in his
patients’ bodies.²⁷ Anesthetics weren’t as commonly used, and when they were, they were drugs
such as cocaine and morphine, which are both highly addictive.⁴ Although huge strides were
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made for surgical practices at this time, some of the surgical techniques used then are now
considered fairly barbaric in comparison to today’s methods.

Seed and Soil Theory
In the wake of radical surgical procedures, another scientist added his expertise to the
larger picture of cancer. Stephen Paget was an English surgeon who came to the conclusion that
cancer cells could spread to other areas of the body and begin the growth of new tumors there, a
concept which Halstead previously had believed to be false.²⁹ Paget hypothesized his “seed and
soil” theory, which stated that cancer could metastasize, or spread to other areas of the body
through the bloodstream, but only when the “seed and soil” were compatible with one another.³⁰
He believed that cancer development relied on the body microenvironment and that new tumors
could grow in different areas of the body if they were suited to the environment.
One of the most important aspects of his argument was that these metastases did not
occur by chance; metastatic activity would only occur if the cancer cells found organs that were
favorable for their growth.³⁰ This discovery allowed scientists to understand more fully the
specificity of different kinds of cancers to their environments. It also allowed cancer researchers
to understand how tumors appeared in different areas of the body than the original tumor in the
case of metastatic cancers: they moved through the bloodstream and did not simply appear
sporadically. This theory added a new dimension to cancer research, as scientists were now able
to understand how new tumors occurred outside of their origin sites within the body and how
cancer cells were able to spread anywhere they “found suitable.”
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Radiation
Around the same time that radical surgeries were being introduced in Baltimore and other
areas of the world, other cancer treatments were being explored. With the new century
approaching quickly, there was a push for scientific innovation and progress in the realm of
cancer research. Scientists in Germany and France began experimenting with electron tubes,
x-rays, and radium. Some of the most notable scientists involved in these kinds of discoveries
were Pierre and Marie Curie. Marie specifically found that a waste ore called pitchblende
contained a new element with surprising radioactive properties, she named her new element
“radium.⁴”
In experimenting with this new element, Marie and Pierre discovered that, when radium
was used to generate x-ray radiation, there was a stark contrast in the pictures taken of the human
body; the soft tissue parts of the hand that was x-rayed appeared dark and shadowy, while the
bones within the hand were a stark white.⁴ This allowed for internal organs to be examined for
the first time without cutting a patient open: x-rays were used to take pictures of a person’s
interior based on the shadows created when the light beams passed through a specific body part.
This also allowed cancer to be detected at an earlier time in the course of the disease in some
cases, providing a more targeted and earlier treatment. Previously, a person could only tell if they
had a tumor if it was large enough to see with the naked eye or feel within their body, so this
development was both exciting and incredibly beneficial.
Radiation can also be used as a tool to treat cancer due to its ability to induce cell death.
Marie Curie learned this the hard way, as she ended up dying due to exposure to high amounts of
radiation. Shortly before the end of her life, Madame Curie developed aplastic anemia, a type of
bone marrow failure that prevents new blood cells from being created.³¹ This was one of the first
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instances in which high levels of radiation exposure was acknowledged to cause a lack of cell
growth. Though Marie Curie’s death was incredibly tragic and sudden after the advent of her
illness, it allowed scientists to explore the possibility of using radiation as a means to curb cancer
cell growth and even cause cancer cells to die. Radiation is commonly used today, either
externally or implanted, to induce damage that forces cell death.³² This targeted cell death is
often used to shrink tumors so that they will be more easily targeted by another form of
treatment, such as surgery or chemotherapy.

Chemotherapy Drugs
In our current era of cancer therapy, one of the oldest and most widely-used cancer
treatments is chemotherapy. Chemotherapeutics are generally described as drugs that attack
cancer cells in an attempt to kill them and thus reduce the growth of cancerous cells within the
body. There are many different classes of chemotherapy, each attacking a different target that is
essential for cancer. One of the first chemotherapy drugs was discovered by Sidney Farber.
Farber was a pediatric pathologist who spent the majority of his days in the laboratories
underneath the Boston Children’s Hospital, researching ways to end childhood leukemia.⁴
Through his extensive research, he discovered that folic acid exacerbated the growth of leukemia
cells within the body. This led him to the discovery of folic acid antagonists, drugs that negate
the effects of folic acid, which aids in the production of DNA in cells. He reasoned that these
antagonists, should work as a treatment to stop the spread of leukemic cells within the body.³³
His use of aminopterin, a known folic acid antagonist, allowed for temporary remissions for
children with acute leukemia.³³ Farber’s discovery of this chemical as a chemotherapy drug
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began a new era for cancer research: one in which different drugs were developed to target
mechanisms of abnormal growth and replication within cancer cells.³⁴
Chemotherapy works by stopping or slowing the growth of cancer cells, and can also
ease some of the symptoms of cancer associated with tumors that are large or in an
uncomfortable place.³⁵ Ultimately, chemotherapy is intended to trigger apoptosis, or cell death,
of the cancerous cells. This normal biological process is often avoided when cancerous cells
have mutated. However, because chemotherapeutics are often delivered through the bloodstream,
it is not possible to target only cells which are cancerous: many healthy cells are killed off in this
process as well. This explains why patients being treated with chemotherapy often lose their hair
or experience gastrointestinal symptoms. The cells lining the GI tract and comprising hair
follicles are dividing and replenishing their supplies regularly, and highly proliferative cells are
most susceptible to these chemicals.
Chemotherapy does not always work in the way it is intended, however. Some tumors
may resist cell death or shrinkage despite high doses of chemotherapy drugs. This resistance is
due either to mechanisms that have been turned off in certain cancerous cells or new mechanisms
that have arisen as a result of the mutations that cause cancer.¹⁰ Additionally, chemotherapy
drugs cannot be used in doses that are too high, or the treatment may cause severe illness that
may be worse than the symptoms associated with the cancer. In these cases, other treatments
such as radiation may be used in communion with chemotherapy drugs, a practice called
“adjuvant therapy.”
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Adjuvant Therapy
The use of adjuvant therapy has become the norm in cancer therapy. Adjuvant therapy is
defined as “additional cancer treatment given after the primary treatment to lower the risk that
the cancer will come back.¹⁷” This type of cancer treatment can involve any kind of cancer
treatment in communion with another, such as chemotherapy, radiation, hormone therapy,
targeted therapy, or biological therapy. Most commonly, adjuvant therapy involves several
chemotherapy drugs being used at the same time with a variety of doses and targets to ensure
every aspect of a particular form of cancer is being addressed. Though the side effects of
multiple chemotherapy drugs being used simultaneously may prove to be severe, it decreases a
patient’s chances of cancer progression or recurrence.³⁶ This kind of cancer treatment is highly
specific to the patient and the type of cancer, so a single effective form of effective adjuvant
therapy does not exist.
A common type of adjuvant therapy is combination chemotherapy. Since chemotherapy
drugs target a specific mechanism or characteristic of cells, mutations may arise that circumvent
the action of the drug being introduced. Adjuvant therapy is commonly used in cancer
occurrences that have advanced past the first stages, such as stage III colon cancer. At this point,
the disease has progressed to involve the lymph nodes as well as invading through the wall of the
colon, so at least two different chemotherapy drugs are used to increase the disease-free survival
rate.³⁷ Using adjuvant therapies and tailoring a patient’s therapeutic plan to fit their specific form
and progression of colon cancer has been shown to decrease the risk of cancer recurrence by
about one-third.³⁴ This supports that, in most cases, using a combination of chemotherapeutic
drugs is the best course of action to treat patients. Though this kind of cancer treatment has seen
high levels of success over the years, there is always room for improvement in cancer treatments
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to increase the rate of patient survival and comfort, while also decreasing the chances that cancer
will recur.

Cancer research today
The realm of cancer research is constantly changing as new technologies and drugs are
discovered. As was seen in the previous historical summary, practices and ideas thought to be
true for centuries are often rejected with the addition of new knowledge to the scientific
community. The main goals of cancer research are to develop treatments that are more effective
in targeting and exterminating cancer and to improve the overall experience of cancer treatment
for patients. This field is incredibly collaborative, and there are many journals and scientific
blogs in which different scientific papers are published for colleagues to read and reproduce in
various lab settings.
Often, scientists will try to manipulate normal bodily functions to use as weapons to
destroy cancer cells or discourage their development and spread throughout the body. For
example, scientists at Yale have recently provided one example of this through their research to
improve an existent immunotherapy known as CAR-T cell therapy. Their research was shown to
“supercharge” this pre-existing therapy and coerce it to attack a wider variety of cancers with
greater accuracy.³⁸ This kind of immunotherapy introduces molecules into the immune system
that are used to detect cancer. Previously, this kind of therapy could only be used to target
cancers without a hard tumor, such as lymphomas or myelomas; however, the scientists behind
this research identified certain genes that can increase metabolism and make T-cell treatments
more effective and dynamic than previous cell therapies.³⁸
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Scientists are also constantly trying to understand the mechanisms of cancer and what
genes influence the occurrence of certain cancer types. Understanding the factors that influence
cancer are important when trying to find the best way to understand how cancer progresses, how
a person is predisposed to developing cancer, and to identify potential targets to combat the
cancer cells specifically. For example, normal cell function relies on a group of enzymes known
as kinases, which regulate protein function in cells. This group of enzymes are often
dysregulated in cancer and are attractive potential therapeutic targets. Every development made
in the field of cancer research contributes one piece to the larger puzzle of the disease of cancer,
and every discovery is vital in understanding how cancer is able to grow and persist within
people’s bodies. Having a basic understanding of what factors – genetic, environmental, or
otherwise – contribute to a person’s predisposition and development of cancer is an important
first step in the understanding of cancer. These genetic predispositions or conscious actions that
are solidly linked to the development of cancer are known as “risk factors.”

Risk Factors
By definition, a risk factor is something that “increases risk or susceptibility” to a
particular outcome.³⁹ In the context of cancer, a risk factor is something that exposes people to
harmful and possibly carcinogenic agents – those that induce the development of cancer. This
increased risk can be accomplished through consumption of or exposure to something potentially
harmful – such as chemicals, toxins, or radiation – or by adopting certain behaviors that can lead
to the development of cancer.³⁹ Risk factors were not well-understood early in cancer research, as
the development of cancer was assumed to be a random occurrence in unlucky people. However,
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as scientists began to understand the mechanisms of this group of diseases more fully, risk
factors were better defined and their mechanisms of influence were understood.
Each risk factor acts in a different way to make the body more susceptible to DNA
mutations and damage, all of which can lead to development of cancer. However, each risk factor
is typically linked to a specific cancer or groups of cancers. For example, UV radiation is linked
to an increased risk of skin cancer caused by the damaging properties of UV rays that come in
contact with the skin, but it would not necessarily lead to the development of lung cancer. The
same goes for smoking; the chemicals found in tobacco would cause damage to the lungs when
inhaled and could cause the development of lung cancer, but would not necessarily cause skin
cancer initially. Because certain risk factors are associated with specific kinds of cancers,
scientists inferred that each risk factor had specific agents associated with them that caused each
cancer. These agents are known as carcinogens.

Early Carcinogenic Agents
Carcinogenic – or cancer-causing – agents come in many forms, whether it be a chemical
such as tobacco, UV rays from the sun, or even infectious agents such as viruses. Each
carcinogen is unique in the way it causes the DNA damage that leads to cancer.³² One of the
earliest identified carcinogens was the soot that chimney sweeps encountered in their daily jobs.
An 18th-century surgeon named Percivall Pott noticed that there was an increase in the number
of scrotal cancer cases and decided to seek out the cause of the problem, rather than trying to
treat the cancer alone. He noticed the trend that the majority of those inflicted with scrotal cancer
worked as chimney sweeps and were exposed to the toxic chemicals present in soot.⁴ In
identifying the causative agent for this particular disease, Pott was able to provide an explanation
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for its incidence in society and help offer a solution that decreased the number of cases of scrotal
cancer that occurred in their population. This opened up an avenue through which to explore
different chemicals associated with risk factors and the DNA damage each agent causes that
leads to cancer-causing mutations.

UV Radiation as a Carcinogen
A well-known risk factor linked to a specific type of cancer is UV radiation. UV rays are
components of the sun’s rays along with visible light and infrared radiation. In particular, UV
rays are harmful when they come in contact with the skin because they can induce harmful DNA
alterations known as thymine dimers.¹⁰ These are covalent linkages of adjacent nucleotide bases
that can affect the shape of the DNA double helix and, therefore, hinder the expression of certain
genes or impact how the DNA is read during transcription. Furthermore, these alterations often
result in mutations as the cell attempts to copy DNA during cell division. Depending on which
genes are affected in this way, skin cancer can form as a result. For example, the p53 gene is
mutated most often in many skin cancer types, and this mutation can lead to the rapid
proliferation of cancerous skin cells that are present in malignant, or harmful, types of skin
cancer.¹⁶
While this type of carcinogen is experienced by most people daily, there are ways to
decrease the sun’s carcinogenic effects. Sunscreen is a useful tool in blocking the damaging UV
rays from the sun and providing a barrier of protection, whether it be physical or chemical.
Additionally, hats can provide shade to areas that are most easily exposed to the sun and provide
physical protection from the sun’s rays. Preventative measures are incredibly beneficial in this
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case, as they are highly effective in preventing the exposure of someone to carcinogens that may
lead to an accumulation of DNA damage and mutations.

Oncogenic Viruses
Specific viruses have also been demonstrated to lead to some cancers. One of the most
well-known examples of a virus acting as a carcinogenic agent is the HPV virus. HPV is a
common sexually-transmitted infection (STI) that causes warts on the genital areas of the body.³⁹
Infection with this virus is incurable, but vaccination is available to decrease a person’s chances
of contracting this particular STI. While HPV infection itself results in (symptoms), several
strains have also been shown to the causative agent in some cases of cervical cancer.¹⁶
Inflammation resulting from breakouts of this viral infection can be an ideal environment for
excess cell proliferation, which provides an environment wherein mutations can develop that
lead to cancerous cell growth. In many cases, the HPV infection will be controlled by the
immune system so that it cannot lead to cancer development. However, in the case of high-risk
strains of HPV, uncontrolled viral infection often leads to cancer.⁴⁰
In addition to causing unnatural inflammation within the body, the HPV virus is able to
alter normal cellular gene expression as it replicates. Through this process, the protective
mechanisms that inhibit abnormal cell division are altered.³² In the case of carcinogenic HPV
strains, two viral oncogenes which encode the proteins E6 and E7 have the ability to inactivate
p53 and pRb genes and alter their protein products.⁴¹ Both p53 and pRb are tumor suppressors
that control cell proliferation, so when their functions are lost, the cells are able to replicate and
divide with the development of DNA damage. The resulting unchecked cell proliferation results
in the build-up of DNA mutations and the eventual development of precancerous daughter cells.
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Thus, HPV is both a carcinogen and a risk factor for cancer, since its replication and genetic
manipulation can predispose women to cervical cancer. While some carcinogens are more
obviously connected to their respective cancers, some are more complex and still being
understood today. One of these is the carcinogenic role of high fat diets and obesity.
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III.

Obesity as a Risk Factor

Obesity
Obesity is defined as having excessive fat storage on one’s body. When considering a
person’s BMI, “obesity” is determined as having a BMI of 30 or above.⁴² Excess fat itself is not
necessarily unhealthy, as fat storage has evolved as a mechanism to store energy in
circumstances of food scarcity. However, persistent obesity can increase the risk for developing
many associated health problems, including diabetes, cardiovascular complications, and some
cancers.⁴³ Obesity can also tamper with metabolism, increase circulating hormone levels, and
cause persistent inflammation within the body. All of the changes obesity makes in the body and
the normal microenvironment make obesity a risk factor for the development of cancer.
There are many factors that influence obesity besides unhealthy lifestyle choices, and this
issue is often much deeper than choices alone. One must not negate the other circumstances that
can lead to obesity: socioeconomic class, age, environment, sex, race or ethnicity, access to foods
lower in fat content, and genetics.⁴⁴ For the purposes of this thesis, these factors will not be left
out, but will be discussed in context at the end of the thesis. In order to explore the biological
effects of obesity as a risk factor for cancer, it will first be discussed how obesity alters a
person’s physiology to generate/develop a susceptible environment for cancer growth. One of the
biggest changes obesity makes within a person’s body is the persistence of low-grade
inflammation.
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The Role of Inflammation
Large amounts of excess fat on a person’s body can lead to a constant state of
inflammation, an immune response within the body.⁴⁵ When the body senses that there is cell
damage due to an invading infectious microbe or germ, the immune system employs strategies
to repair the damage and restore the body to its homeostatic, or balanced, state. Inflammation
occurs when white blood cells, which fight infection and illness, are present in high numbers at
a particular site within the body, resulting in observable swelling and formation of pus.⁴⁶
Immune cells remove and digest damaged cells so that new ones can grow and take their place.
While this action is beneficial in the short term when trying to heal cuts and bruises or respond
to a local infection, it can be detrimental over a prolonged period of time.
Similar to the environment created by an HPV infection, the constant state of
inflammation present in obese individuals means constant proliferation of cells. This is due to
the “damage” sought by the inflammatory response never being fully fixed, leading to a
constant surveillance and replacement of cells. If left unchecked, constant proliferation can
result in errors in DNA replication and cells that defy normal control mechanisms, allowing
them to proliferate indefinitely.⁴⁷ The relationship between inflammation and cancer growth
leads to a greater understanding of how a body’s microenvironment affects its susceptibility to
cancer growth.⁴⁸

Fats as Nutrients
Fats are important nutrients used by the body to fuel a large number of functions. Fats,
like other energy-rich molecules such as carbohydrates, are made up of carbon chains of
different lengths and structures. Fats are important for energy production and storage, and can
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function in a variety of other ways, such as cofactors for enzymes, signaling molecules, and
antioxidants.⁴⁹ Fats are also necessary within the body for providing essential fatty acids,
molecules that the body cannot make on its own, that aid in bodily functions such as blood
clotting or brain development.⁵⁰ Fats are vital for many normal processes within the body, but
not all fats are beneficial. Some can lead to a number of health issues and excess adipose tissue
accumulation if consumed in large amounts. Adipose tissue is used to store fats within the
body and is important for normal body functions when present in healthy amounts.
Fats are classified in two ways based on their chemical structure: unsaturated and
saturated. Saturated fats contain no double bonds between the carbon-carbon bonds that make
up their structure, so the molecules are well-ordered and can accumulate more easily in a
stacked formation. Saturated fats are found in fats that are often solids at room temperature,
such as butter, cheese/dairy products, meat products, and others. In the body, saturated fats
raise levels of harmful LDL cholesterol. LDL cholesterol molecules are low-density
lipoproteins that transport fat molecules throughout the body. This kind of cholesterol is known
as “bad” cholesterol because it can easily clog arteries and cause heart attacks due to their
structure and physical properties.⁵¹ On the other hand, unsaturated fats improve cholesterol
levels and and reduce inflammation, decreasing a person’s chances of having a heart attack or
developing heart disease. These fats contain one or more double bonds between the carbons in
their structures, making them more disordered and difficult to interact with other fat molecules
in the same stacking manner that saturated fats employ.⁴⁹ Unsaturated fats are normally found
as liquids at room temperature, such as in olive, peanut, and canola oils, but can also be found
in avocados, seeds/nuts, and fish.⁵¹ These kinds of fats are generally known as “good” fats and
are generally a healthy part of a person’s diet when consumed in reasonable amounts.
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Effects of High Fat Diets
Fats are beneficial when consumed in moderation, but when a person consumes high
amounts of fat, specifically the saturated fats that are more processed, it can lead to ill-health.
When a body processes fat molecules, it either sends the broken down fats to muscle cells
(myocytes) to be burned for energy or to the fat cells (adipocytes) to be stored for future energy
use.⁴⁹ While this process is necessary and normal to fuel a body’s activity, an excess intake of
fat can lead to build-up of adipose tissue This can also induce the proliferation of more
adipocyte cells for increased fat storage. This process, often coupled with a lack of exercise
that normally burns the fat stored in the adipocytes for energy, leads to the accumulation of
adipose tissue and often results in obesity.⁴⁷ Because high fat diets that lead to obesity are able
to predispose a body to developing cancer, they are considered a type of carcinogen. Colon
cancer has been shown to be strongly linked with eating behaviors, as one study shows that
increased amounts of red or processed meats high in fat content are linked to a rise in colon
cancer instances in younger adults.⁵² This points to the conclusion that people who consume
higher amounts of fatty meats and other fatty foods that are capable of contributing to excess
adipose tissue are more likely to develop some kind of CRC.

Cancer and High Fat Diets
Many studies have shown the adverse effects of feeding high fat diets and how they can
lead to an increased development of cancer. Many of these studies use mouse models because it
is unethical to use humans in studies inducing cancer. They are easy to grow in a lab and have
many of the same features and diseases as humans; they also possess genomes that are
well-understood and easily-manipulated in different experimental settings.⁵³ A study published in
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the Endocrinology journal found that feeding mice a high fat diet resulted in a dramatic increase
in cell proliferation – about a 30% higher rate of tumor development after 1 week – specifically
epithelial cells in the prostate, pancreas, and colon.⁵⁴ These results are in agreement with those
from other studies, in which various animal specimens have seen a decrease in tumor
development and progression when fed diets lower in calorie content.⁵⁴ Finally, a study from the
Chen lab at Illawarra Health and Medical Research Institute observed that mice that had
developed obesity due to high fat diet consumption were also seen to develop 3.4 times the colon
polyps that mice fed a low-fat diet developed.⁵⁵ These results support a link between ingesting
high fat diets, both in the development of obesity and in the development of obesity-related
cancers.
Feeding a low-fat or restricted diet has also been demonstrated to slow cancer
progression in mouse models. When mice possessing breast tumors were fed calorie-restricted
diets (with a 20-40% reduction in total energy intake,) the growth of the tumors was slowed in
many cases.⁵⁶ This study also showed the impact of a high fat diet on weight gain and how
gaining weight affects cancer recurrence and mortality in mice models. This mouse data is
supported by human observation. Specifically, people that gained a significant amount of weight
in the 5 years before a prostate cancer diagnosis saw greater cancer recurrence, while those who
gained weight in the 5 years following a cancer diagnosis exhibited higher rates of mortality.⁵⁶
The results of this study support the idea that high-fat diets aid in cancer progression, while
lower-fat or calorie restricted diets being used to combat obesity can decrease tumor growth and
slow cancer progression in many different types of cancer. This is because different components
have different effects on the digestive system, specifically the intestines and the colon
comprising the “gut.”
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The gut is constantly generating and replenishing cells for this specific area of the body,
as digestive acids are constantly moving through and causing damage to the intestinal lining.
Because of this, there is a population of stem cells present in the gut to replenish the lining as
needed.⁵⁷ It has been found that mutations in these stem cells predispose patients to developing
colorectal cancer. A study carried out at the Salk Institute demonstrated that the consumption of
high fat diets can upset the balance of bile and acids within the digestive system, which can
trigger signals that allow potentially cancerous cells to thrive and develop into cancerous
masses.⁵⁷ This explains why there is an increase in colorectal cancer cases specifically in younger
individuals, as they are often more exposed to high fat diets and can use this habit to accelerate
their development of this form of cancer, which normally takes decades to develop.⁵⁷
Another project carried out by researchers at MIT confirmed how influential diet is in the
overall maintenance of the gut microbiome. The gut microbiome is composed of microorganisms
that aid in digestion and aids in controlling many other aspects of a person’s health.⁵⁸ Many
factors can influence the microbiome and its components, but diet plays a large role in its
functions. Diets that are higher in fats, sugars, and cholesterol were shown to contribute to
intestinal or colorectal tumor formation through a variety of mechanisms.⁵⁹ In instances of excess
fat consumption, the intestinal stem cells were manipulated in their proliferative abilities due to
alterations in their cellular structures, which enhanced their ability to regenerate rapidly.⁵⁹ High
amounts of lipids consumed can encourage the body to engage in a peroxisome
proliferator-activated receptor (PPAR) transcriptional program, which changes the properties of
the intestinal stem cells and makes them more proliferative in their activities.⁵⁹ PPAR involved in
intestinal stem cell production also exhibit downstream effects, such as lipid absorption,
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cholesterol trafficking, and enteroendocrine cell function,⁵⁹ all of which can affect the gut
microenvironment.
Excess nutrients, specifically fats, within the microenvironment of the gut can also lead
to the activation of pro-inflammatory pathways and sustained inflammation.⁶⁰ In cases of obesity,
there is an increase in reactive oxygen and nitrogen species from aerobic metabolism, which can
allow inflammation to persist and have damaging effects.⁶⁰ It has been seen in human studies that
high amounts of adipose tissue, as seen in obesity, is a much stronger risk factor for cancer than
high amounts of dietary fats or carbohydrates. This is because the fat present in cases of obesity
have far more influential effects on the body than do dietary fats fed in high amounts.⁶⁰ Both are
harmful and can be risk factors for CRC, but their effects are exacerbated when they are present
in communion with one another.
Despite the connection between colon cancer and the consumption of high fat diets as
seen in many studies utilizing mice models, there is not a single causative link between obesity
and the development of colon cancer, which makes an already multifaceted issue even more
complicated. Instead, several physiological changes induced by consumption of a high fat diet
influence the development of cancer, as briefly indicated above. Additional factors involved in
this linkage between excess adipose tissue retention and cancer progression are the effects on a
person’s endocrine system (hormone signaling), increased occurrence of angiogenesis (formation
of blood vessels), and alterations in immune signaling (ability to fight off disease) within the
body. Each of these three physiological processes are also linked to cancer progression, and
exploring each in detail can offer some insight into their relationships with cancer and obesity.
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IV.

The Endocrine System

Cell Signaling
Cell signaling plays a vital role in the three physiological processes mentioned above.
Signaling pathways are necessary for cell, tissue, and organ functions and regulate many aspects
of normal cell behavior. These signaling pathways involve the detection of a stimulus on the
surface of a cell’s plasma membrane, the transfer of the signal into the cytoplasm, and the
transmission of the signal to the effector. This often results in a conformational or structural
change of the proteins present.¹⁰ Heavy regulation of signaling pathways is necessary so that
signals will not be sent at inappropriate times or cause unwanted effects.
Because multicellular organisms such as humans are so complex and consist of many
tissues with different structure and functions, it is important for cells to be able to communicate
with one another.¹⁰ Some processes that require extracellular signaling molecules are cell
division, energy usage, and apoptosis. Cell signaling is paramount in making sure that all of the
tissues in the body are interacting as they should and “behaving” appropriately. Each signaling
pathway has the same components: a ligand, a target cell, and receptor proteins, all of which
initiate a cellular response; this is illustrated in the figure below (Figure 3):

Figure 3: The Cell Signaling Pathway and its Components⁶¹
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The signaling molecule, or ligand, is sent by an extracellular signal to the target cell
where it is to be received. Receptor proteins in or on the target cell contain binding sites for the
signaling molecules of a given pathway, which bind specific ligands.¹⁰ This usually results in a
conformational change to the receptor. If this process occurs at the cell’s surface, the signal is
then transduced, or transmitted, from the cell membrane to the cell’s interior. A host of additional
proteins and enzymes are often involved to transmit the signal to the cell’s nucleus, where the
signal ultimately results in alterations in gene expressions.¹⁰ It is the alterations of the cellular
proteome that carries out the cell’s response to the signal. One example of a signaling pathway
response is the production of a transcription factor, a protein to aid in the expression of a desired
gene.⁶¹ Though the components mentioned above may take on different forms depending on the
specific pathway, they are vital aspects of every signal transduction. Each is needed in the right
amounts at the right time in order for body processes to function as they should.
One example of a signal transduction pathway is the insulin pathway, which is essential
for cells to produce cellular energy in response to food. When a person eats something
containing glucose, a type of sugar, the body will signal for the process of glycolysis to begin.
The breakdown of glucose is part of a process termed cellular respiration that allows the cell to
produce a usable form of energy: ATP.⁶² When food enters the digestive tract through the mouth,
the particles are recognized by the body as containing nutrients to be used as energy, and the
body signals for enzymes to begin the breakdown process through a molecule known as insulin,
which will be discussed in more detail below.⁴⁹ The chemical reactions that carry out the
digestion of food and the use of that energy to build cellular molecules are known as a person’s
metabolism, which is controlled by a system known as the endocrine system.
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The Endocrine System
The endocrine system is one of the most important systems in the body, though it is not as
well-acknowledged as others like the nervous and circulatory systems. It utilizes a variety of
organs such as the sex organs, the pancreas, and sections of the brain like the hypothalamus and
the pituitary gland to control hormones and associated body processes.⁶³ Importantly, the signals
of the endocrine system reach throughout the entire body, having impacts across all body
systems. In this way, it is similar to the central nervous system (CNS) though it regulates
processes using chemical signals as opposed to the electrical signals utilized by the CNS. Often,
these two organ systems work together to carry out cell signaling and secretory activity.⁶⁴
The CNS is not the only organ system that interacts closely with the endocrine system.
The pancreas, for example, is an organ of the endocrine system that reinforces the digestive
system and helps maintain blood glucose levels using its hormone products. It secretes both
insulin and glucagon in different situations to maintain the proper concentration of glucose
circulating in the blood at a given time. (Figure 4)

Figure 4: The Regulation of Blood Glucose by the Pancreas⁶⁵
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As seen above, the pancreas receives signals based on the levels of glucose in the blood
via the nervous system. If the blood glucose is low, the pancreas will be signaled to release
glucagon, a hormone that functions to promote the breakdown of glucose stored in the liver as
glycogen.⁶⁴ This cascade of events ultimately ends in an increase of glucose in the bloodstream.
Conversely, if there is too much glucose in the blood, the pancreas will be signaled to release
insulin. Insulin signals fat cells to take up and store the excess glucose present in the blood to
restore the levels to their normal homeostatic, or steady state.⁶⁵ This is one example of how an
endocrine organ functions: each receives a signal and initiating an action (the release of a
hormone.) In order to understand how the endocrine system functions, it is first important to
explore what hormones are and how they are used to send signals throughout the body.

Hormones
Hormones are signaling molecules that are secreted by endocrine organs and regulate the
physiology of target tissues.⁶⁶ Since these signaling molecules are hydrophobic, they are able to
cross membranes to bind targets inside cells directly, similar to the action of a transcription
factor. Hormones travel through the circulatory system to reach target cells across the body
(Figure 5) and have important roles in different body functions, such as the timing of a woman’s
menstrual cycle or in the regulation of a person’s metabolism.

Figure 5: Depiction of Hormones Traveling through the Bloodstream⁶⁷
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Each hormone functions using a distinct cellular signal pathway, resulting in a variety of
outcomes that depend on which tissues are involved. As mentioned above, insulin and glucagon
function to control blood glucose levels based on signals received by the pancreas from the
nervous system.⁶⁶ These two hormones have many different target cells in tissues throughout the
body because of their role in the blood and circulatory system, but not all hormones are as
widely-spread throughout different organ systems.
Some hormones are more specific in their targets and only influence a few organs in their
secretion. For example, estrogen is secreted by the ovaries to regulate the occurrence of the
menstrual cycle and maintain pregnancies when they occur.⁶⁵ The main target of this hormone is
the uterus, but there can be effects seen in other reproductive organs. Estrogen levels fluctuate
depending on the timing of the cycle and what the woman’s body needs in order to prepare the
uterus for possible egg fertilization and implantation. Again, this fluctuation and the presence of
the hormone estrogen is maintained by cell signaling from the CNS. Estrogen also uses the blood
to travel and signal for some effect, but is not a widely-spread or used by as many organs as
insulin.⁶⁴
A final example of a hormone’s function is that of the thyroid hormone. This hormone is
produced by the thyroid gland and controls a variety of functions, such as metabolism and energy
usage.⁶³ These functions are essential in order to maintain homeostasis and control the usage of
energy within the body. When a person’s metabolism is high, they burn energy more easily and
will see less retention and storage of fat within the adipocyte cells; when metabolism is lower, a
person may have more difficulty burning energy efficiently or losing excess fat stored in his or
her body.⁶² Metabolism is largely controlled by the thyroid gland and its hormone products, T3
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and T4, which means a person’s energy efficiency depends upon this endocrine organ’s
functions.⁶³

Hormone Pathway Disruptions
Hormone pathways’ functions are as diverse as the cell signaling pathways that control
their secretion. However, a mistake within a hormone pathway can cause imbalances in nutrient
or ion concentrations in the body, which hinder proper body system functions.⁶⁸ Any disruption
in the endocrine system can have detrimental effects on its targets, especially when there are
insufficient amounts of necessary hormones or their protein products. Simply put, a hormone
imbalance occurs when there is too much or too little of a hormone present in the body. Some
common causes of hormone imbalances include alteration in endocrine gland physiology, high
levels of stress, or conditions such as eating disorders.⁶⁹
Due to the diverse effects of many hormones, altered hormone levels can induce a
variety of signs and symptoms, including fatigue, muscle weakness, insomnia, infertility, weight
gain, and many others.⁶⁸ Additionally, hormone imbalances can disrupt normal cell signaling
pathways so that normal functions, such as metabolism and energy production, are not carried
out as efficiently as they should. This variation from proper hormone pathway functions can lead
to an improper storage of energy and excess fat retention.

Effects of Obesity
The development of colorectal cancer (CRC) is influenced by the endocrine system in a
number of ways. While few hormones are known to directly increase or decrease a person’s
chances of developing CRC directly, some modifications made by obesity can change how the
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endocrine system works in certain pathways.⁷⁰ Hyperinsulinemia and insulin resistance may be
linked to the development of colorectal cancer, and both conditions can be induced by obesity.⁶²
Hyperinsulinemia occurs when the insulin concentration present in a person’s blood is higher
than the levels normally present.⁷¹ This means that there are physically more molecules of the
hormone insulin in the blood of obese individuals, which can lead to a form of insulin resistance,
usually in type 2 diabetes.
Insulin resistance is often caused by an imbalanced diet, inactive lifestyle, and obesity
and can result in decreased function of the hormone insulin, though it may be present in normal
amounts.⁷⁰ In this case, the amount of insulin secreted by the pancreas remains the same, but its
function is greatly decreased and can lead to a higher blood sugar than is normally desired. Both
the elevation of insulin levels and a decrease in insulin function efficacy can disrupt the
endocrine system and tamper with the body microenvironment that exists because of it.
Beyond insulin, there are several other hormones involved in the processing of calories
from food to produce and store energy. One of these is leptin, a hormone that can cross the
blood–brain barrier and bind to presynaptic neurons in the CNS. Presynaptic neurons are nerve
cells that fire neurotransmitters (a kind of signaling molecule secreted by neurons) as a result of
an action potential moving down its structure.⁶⁴ It also controls appetite, the desire to consume
food, and energy expenditure, the body’s utilization of calories to produce energy⁷⁰ through a
negative feedback loop.
Normally, high levels of leptin signal the body to decrease food intake and increase
energy expenditure to maintain the balance of nutrients. However, this is not the case in obese
individuals. Those with excess adipose tissue have high levels of leptin, but lack the normal
response, which suggests leptin resistance, or the inability to “hear” this signal, within the body.
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If left unchecked, the continuously elevated levels of leptin in the bloodstream can lead to tumor
proliferation.⁷² When leptin signaling cascades involved in cell replication and division are
altered due to DNA mutations, the cells may contain mechanisms that prevent them from
proliferating normally. The abnormal functions gained by mutated DNA in these cases may
allow cells to grow continuously, leading to a tumor.⁷²
Adiponectin, on the other hand, is a protein secreted by white adipose tissue, which is
typically used by the body to store energy as fat. This protein has opposite effects from that of
leptin. Adiponectin regulates glucose levels in the bloodstream and aids in the breakdown of
fatty acids; it can also exhibit anti-inflammatory action under normal circumstances.⁷³ The levels
of adiponectin, also known as an adipokine, are much lower in obese individuals than in leaner
ones due to the presence of low-grade inflammation. Adiponectin also acts as a hormone to
sensitize the body to insulin, which decreases its effects on a person’s blood glucose and can lead
to conditions such as type 2 diabetes and hyperinsulinemia.⁷³ This means that in an obese
individual, there are normally higher levels of leptin and lower levels of adiponectin than are
seen in an individual lacking excess adipose tissue.

Endocrine Modifications that Lead to Cancer
The hormones leptin and adiponectin work normally to antagonize the effects of the
other, so any change in their ratio changes the body’s overall cell signaling and proliferative
abilities.⁷² Without the proper amount of adiponectin to maintain the normal levels of leptin, this
hormone is able to signal for cell growth to occur more rapidly, which is a hallmark of cancer.
Additionally, adiponectin normally has tumor-suppressing actions against inflammatory
cytokines such as leptin when both are present in the body in normal amounts; however, when
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leptin levels are much higher than those of adiponectin, this action does not occur normally,
making it an ideal situation for the uncontrolled proliferation of solid tumor cells.⁷³ Because of
the interaction of these two endocrine products, along with others, the endocrine system plays a
large role in the proliferation of cells and can increase the chances of developing some form of
cancer as an obese individual.⁷⁴ Understanding the ways in which obesity affects adiponectin and
leptin in the context of cancer can lead to a better understanding of how obesity predisposes a
person to cancer.
Specifically in cases of CRC, adiponectin and leptin play roles in colon tumor
proliferation for a variety of reasons. First, along with the previously-mentioned effects on
insulin resistance, adiponectin also plays a role in several cell signaling pathways between colon
cells. In one study, researchers found that adiponectin has receptors on normal colon epithelium
tissue, and these receptors are also found on cancerous colon tissue. These adiponectin receptors
can interact with adiponectin and control the actions of leptin.⁷⁵ When adiponectin is present in
the proper amount, its effects can decrease the amount of leptin that can act as a carcinogenic
factor. However, in obese individuals when the balance is thrown off between adiponectin and
leptin, these actions do not occur.
Additionally, adiponectin has some control over tumor necrosis factor alpha (TNF-α,)
which is a cytokine involved in the process of apoptosis. In this case, however, adiponectin
(when present in the incorrect amounts) serves to inhibit cascades involving TNF-α, which
inhibits the cell’s ability to undergo controlled cell death.⁷⁵ Apoptotic actions are a vital part of a
cell’s life cycle, and if a damaged cell is unable to undergo apoptosis due to an interference in the
signaling cascade, it will be allowed to live “immortally.¹⁰” This “cell immortality” becomes an
issue if cells with damaged or mutated DNA are allowed to live longer than they should and pass
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on their abnormal DNA to future cells. This kind of evasion of cell death is an important
hallmark of cancer, which is commonly seen in CRC tumors.
Hormones and cell signaling pathways that are impacted by the condition of obesity have
implications outside of these specific pathways that also pertain to colon cancer. Because obesity
causes excess adipose tissue and inflammation throughout the entirety of a person’s body, every
area and organ system is impacted by the changes it induces. The circulatory system is not one
that is easily suspected to undergo changes due to obesity and inflammation; however, another
hallmark of cancer deals with this system and tampers with its normal cell signaling abilities,
opening another avenue through which to explore colon cancer.
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V.

The Effect of High Fat Diets on Angiogenesis

Angiogenesis: A Hallmark of Cancer
A second factor that influences cancer development is angiogenesis. Angiogenesis is the
recruitment of blood vessels to new areas of the body to provide nutrients and oxygen to
proliferating cells.⁷⁶ This is a normal and necessary process within the body, especially when
tissues are developing or healing. In the context of cancer, however, this normal body function
can be detrimental, as it provides blood to developing cancer cells in the form of a tumor and
sustains them as they proliferate to generate more mutant cells.⁷⁷
Angiogenesis is initiated by tumors when they reach a state of hypoxia, or deprivation of
oxygen. The larger the mass of cells that compose a tumor becomes, the more difficult it is for
cells at the tumor’s core to gain access to the oxygen and nutrients they need to survive.⁷⁸ The
presence of tumor hypoxia leads the cells to signal for angiogenesis. This is a vital aspect in the
development of cancer because an excess of new cells require a new source of nutrients and
oxygen to sustain their growth. It also provides a potential way to escape the tumor and spread to
other parts of the body, a phenomenon known as metastasis.
The process of angiogenesis is also taken advantage of in those who have excess adipose
tissue on their bodies, specifically in obese individuals or those who consume high levels of fat
regularly. The excess adipose tissue resulting from obesity requires the formation of new
capillaries and blood vessels through angiogenesis to provide for all of the excess tissue within
the body. This encouraged growth can allow for the vascular web to grow extensively and open
the door for potentially malignant cells to hijack the system of angiogenesis for its own benefit.
Many tumors that develop in the colon or rectum are reliant on angiogenic action for their
survival.
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One way angiogenesis occurs is mediated via hormone signaling through the secretion of
adiponectin from adipose tissues.⁷⁴ Adiponectin exhibits both anti-inflammatory and
anti-proliferative actions, so it is highly beneficial to cells in normal amounts. This molecule
relies heavily on insulin in order to be made and secreted, but often, obese individuals experience
some level of insulin resistance and lower levels of adiponectin concurrently.⁷³ The decrease in
the levels of this hormone provides a mode through which angiogenesis can occur spontaneously
with greater ease, as the tumor-suppressing action (usually the inhibition of angiogenic activity)
exhibited normally is lost when low levels of adiponectin are present.⁷⁴ The absence of this
hormone could be one cause of angiogenesis in obese individuals, though it is not the only thing
that can influence this phenomenon.

Cholesterol and Adipogenesis
As mentioned previously, there is an association between consuming high levels of
saturated fats and increased LDL cholesterol levels. Additionally, there is some association
between dietary cholesterol and adipogenesis, or the growth of new adipose tissue, though the
link is not yet clearly understood.⁷⁹ Cholesterol is a type of lipid found in the blood that is an
important component in the structure of animal cells. It is vital in the production of cell
membranes, hormones, and vitamin D to be used by the body.⁷⁹ The body’s normal sources of
cholesterol are made by the liver, but cholesterol can be absorbed into the bloodstream by
different foods that are eaten. Because of the waxy and fat-like properties of this lipid, it is
insoluble in water and can easily accumulate within blood vessels if there is too much present
and aggregating together.⁴⁹
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Different kinds of cholesterol are found in people’s diets: HDL (high density lipoprotein)
and LDL (low density lipoprotein.) As we previously discussed, HDL is commonly known as
“good” cholesterol, as it functions to remove cholesterol from the blood and return it to the liver
when it can be processed in useful ways.⁴⁹ LDL, on the other hand, is known as “bad” cholesterol
and is capable of sticking to arteries and forming plaques on the side of blood vessels, which can
lead to heart attacks and other blockages of blood flow.⁴⁹ Cholesterol is often an important factor
that affects cell signaling and is involved in crucial functions of the CNS, so any abnormalities
with cholesterol levels can have catastrophic consequences beyond the buildup of plaques in
blood vessels.
Cholesterol has also been shown to affect angiogenesis occurrence when it is present in
large amounts. One study demonstrated that too much cholesterol in a person’s blood increased
the number of available lipid rafts, which are areas in the plasma membrane where receptors are
able to initiate signaling pathways that lead to angiogenesis.⁸⁰ Since cholesterol is often present
in high amounts in diets containing lots of fat, continuous consumption of such diets can lead to
an increase of cholesterol levels. This increased cholesterol in the bloodstream provides another
way to increase the production of blood vessels and allow cancer to develop.⁶⁴ An additional
means through which blood vessels can be manipulated to provide tumors with sustenance is
through the disruption of signaling pathways.

VEGF Signaling Pathways

In the case of metastatic colorectal cancer (mCRC), there are several signaling pathways
that greatly influence the incidence of angiogenesis and sustain the proliferation of mCRC. The
first of these is vascular endothelial growth factor (VEGF) and its receptors. VEGF is known to
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play a significant role in the process known as “angiogenic switch,” in which proangiogenic
signals from the tumor trigger the formation of new vascularization.⁸¹ This angiogenic switch
involves vessel dilation, detachment of multi-functional cells within the capillary walls,
angiogenic sprouting, and eventually new blood vessel formation.⁸² The figure below depicts this
phenomenon (Figure 6):

Figure 6: Diagram of the Mechanism of Angiogenesis⁸³

Angiogenic factors such as VEGF initiate the activation of endothelial cells (EC) which
are used to create new blood vessels when they bind to their receptors on the EC membranes.⁸³
Once activation occurs, the ECs are able to migrate and proliferate in new locations as needed.
The cells will form the necessary framework of the vessels and undergo remodeling to ensure
they create effective channels through which to carry blood. The new branches of blood vessels
are stabilized, and each is able to supply the surrounding area with increased blood and nutrients
due to their new proximity.⁸³

Braeuner 49
VEGF levels are particularly elevated in mCRC and generally indicate a poor prognosis
for the patient.⁸² VEGF levels are significantly upregulated in CRC tumors than are found in
normal colon tissue, and this increased expression of VEGF can contribute to a tumor's influence
on angiogenic actions.⁸² Tumors with high levels of VEGF expression can signal for the growth
and branching of new blood vessels to provide the growing mass of cells with enough nutrients
to sustain it. The mechanisms that regulate VEGF expression are complex, however. The
upregulation of VEGF-A has been correlated with higher levels of adipose tissue within the
body. Further, in one study, upregulation of VEGF-A decreased the amount of white adipose
tissue and lead to increased supply healthy tissues with oxygen and nutrients.⁸⁴ This allows
adipocytes to grow and flourish, avoiding hypoxia and increasing the viability of the cells
through new pathways of vascularization. However, in the context of colon cancer, this normally
beneficial trait can be hijacked and used to propel the progression of cancer forward with
increased angiogenesis and the sustainment of inflammation and cell proliferation.

EGFR Signaling Pathways

Another signaling pathway that is important in the angiogenic action of mCRC is the
epidermal growth factor receptor (EGFR) pathway.⁸¹ EGFR is a glycoprotein whose main ligand
is epidermal growth factor (EGF), a signaling molecule that stimulates cell growth.⁸⁵ In normal
cells, EGF levels are kept low so that unwanted angiogenesis or cell proliferation does not occur,
but this function is manipulated by cancer cells to upregulate EGF production to increase EGF
binding.¹⁰ This means that a higher expression of EGFR and EGF signaling can result in
unexpected cell proliferation, usually in the form of a tumor. Similar to the function of VEGF,
tumors with mutations or truncations on specific gene domains will have the ability to signal
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EGFR outside of normal conditions, and this can contribute to the growth of a tumor. EGFR is
overexpressed in 60-80% of CRC cases and it uses mechanisms both to disrupt the cell cycle and
aid in activities such as angiogenesis.⁸⁶ (Figure 7)

Figure 7: Simplified Depiction of EGFR Pathways⁸⁷

This figure demonstrates a simplified version of the EGFR pathway. The binding of the
EGF ligand to its receptor initiates a cascade of events that lead to expression of
angiogenesis-promoting genes.⁸⁷ Therefore, while disruptions in the EGFR pathway are often
associated with cell proliferation directly, this can also initiate the process of angiogenesis.¹⁰ This
signaling pathway is complicated and relies on a variety of factors to be carried out; however, the
initiation of the cascade through the binding of EGF to EGFR is an important step in the
initiation and progression of angiogenesis.
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Targeted Treatments for Angiogenic Pathways

Because alterations in both VEGF and EGFR signaling pathways are both frequently
observed in cases of mCRC, they have become effective chemotherapeutic drug targets. Based
on the mechanisms used by each signaling pathway, different parts can be targeted to inhibit the
steps that promote angiogenic activities. One treatment that is often successful in targeting EGF
and VEGF pathways are inhibitory monoclonal antibodies. Monoclonal antibodies are
lab-produced molecules made to mimic or enhance immune cell action.¹⁰ These molecules can be
synthesized to target specific gene products (such as EGF and VEGF) and bind them before they
can bind their receptors, therefore inhibiting the rest of the signaling pathways in which they are
involved.¹⁰ This ultimately serves to starve the cells that comprise the tumor, inhibiting tumor
growth.

Within this class of treatment options, Cetuximab is a monoclonal antibody drug that has
been developed to target EGFR in cases of mCRC. While its efficacy is still being tested to
combat various stages of mCRC, using this drug alongside other chemotherapy drugs in future
research shows promising results.⁸⁸ Efficacy of these kinds of drugs also depend upon which
mutations are present in a person’s specific type of CRC, so not every monoclonal antibody
treatment will prove successful for every patient. Panitumumab is another monoclonal antibody
drug that targets mCRC, specifically EGFR pathways. It showed effective results in clinical trials
in many cases of CRC, but was ineffective against specific mutations in genes called KRAS and
NRAS.⁸⁸ This leads to the conclusion that, though monoclonal antibodies that inhibit the
VEGF/EGF signaling pathways can be effective in many cases, they are not always the best
action of treating cancer cells that are involved in initiating angiogenic actions.
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Looking at angiogenesis as a hallmark of cancer and identifying which factors affect it
most heavily is an important part of understanding how mCRC hijacks body systems so
effectively. Higher levels of fat and the resulting alterations in cholesterol and adiponectin, are
contributing factors in the progression of cancer through angiogenic activities. It is important to
examine this group of diseases through a wide lens to ensure that a variety of factors are
acknowledged when trying to understand how cancer functions. An immunological approach to
the issue of obesity-related CRC can further reveal the complexity of the influence excess fat has
on the development of this kind of cancer.

Braeuner 53
VI.

Immunology and Obesity

Cancer incidence is strongly linked to the microenvironment in which a tumor is found.¹⁷
In order to understand how this is understood, how the immune system shapes and responds to
specific microenvironments.

Immunology
Immunology is a branch of biological science that focuses on the components and
function of the immune system, which works to maintain homeostasis within the body and
protect it from infections and diseases.⁸⁹ The immune system is made up of a network of tissues
and organs and functions via a complex array of cells and molecules. This system consists of two
overarching responses to disease: innate (natural) and adaptive (acquired.⁹⁰) These immune
responses enable the body to distinguish and attack pathogens with accuracy. Innate immune
responses use cells such as macrophages, neutrophils, and other phagocytic cells to incite an
inflammatory response in the affected area of the body. These specific cells are responsible for
recognizing foreign pathogens within the body and use an inflammatory response to engulf and
break down the foreign body.⁹¹ Because a variety of infectious agents can cause disease, the
innate immune response serves as a general method to recognize and attack foreign invaders.
Conversely, adaptive immune response is targeted to specific pathogens. It involves the
proliferation and action of B and T cells, which are immune cells that target antigens, or pieces
of foreign substances.⁹⁰ B and T cells are specific lymphocytes, or white blood cells, that are
generated in the bone marrow in adults and attack pathogens or produce antibodies, which target
specific antigens using proteins called immunoglobulins to bind and inactivate them.⁹² Normally,
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adaptive and innate immunity work together within the body to combat foreign pathogens and
maintain a healthy body.⁹⁰
Over the past decade, it has become increasingly clear that the immune system also
protects the body against itself, as a properly functioning immune system is important for
limiting the growth and spread of cancerous cells. Historically, it was known that immune cells
were “programmed” to fight off foreign invaders specifically, but they are able to identify and
target cancer cells naturally as well.¹⁷ This is usually carried out by tagging cancerous or harmful
cells with specific antigens so that immune cells can target them and initiate their breakdown.¹⁷
Scientists are working to harness the abilities of these particular immune cells, such as B and T
cells, as a form of immunological cancer treatment. These treatments should enhance the body’s
immunological abilities and target cancer cells more accurately than the immune system can on
its own.
Cancer and immunology have a unique relationship, as cancer often occurs when the
body is unable to recognize and combat abnormal cell growth using normal immune functions.
Targeting and breaking down cancer cells can be challenging for immune cells to accomplish, as
cell proliferation is a normal and extremely common function; the immune system has to “learn”
to distinguish normal from abnormal cell growth in order to combat cancer cell proliferation.
Furthermore, since it is the body’s own cells that are proliferating beyond control, the immune
system would recognize these cells as “self” and not a foreign invader.³² Because of this, tumors
are often able to evade immunological attack. Immune responses such as inflammation can also
aid in cancer’s ability to evade the body’s attack.
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Inflammation
Obesity is one change within the body that can affect the overall function and accuracy of
the immune system, given its ability to change the body’s microenvironment. Immune cells that
combat a foreign body or infection using innate immunity cause the specific area of the body to
become inflamed. This physical response of the immune cells is caused by inflammatory
mediators making it easier for immune cells to travel to and respond to the pathogen present.⁴⁶
This is normally a sign of healing and means that a foreign invader is being combatted and cells
are proliferating in a healthy way to replace the damaged ones being recycled. Inflammation can
also increase blood flow to a certain area of the body and dilate small blood vessels, which
allows blood carrying immune cells to reach the affected area more efficiently.⁴⁶
In the case of obesity, however, there is a constant, low-grade inflammation that persists
much longer than normal. The excess of adipose tissue on a person’s body contains an excess of
macronutrients, which nourish the cells and allow them to grow. This excess of nutrients also
stimulates the release of hormones and other molecules that elicit an inflammatory response.⁹³
Since the excess adipose tissue is not easily lost, this allows inflammation to persist over time in
low but influential amounts. As long as the chronic inflammation exists, so does the recruitment
of new blood vessels and new tissues, as well as the production of inflammatory cytokines and
hormones.⁴⁵ This persistent inflammation is grounds for constant cell proliferation and can lead
to unwanted and sometimes harmful cell mutations and possible tumor growth.⁷⁶ Inflammation is
also involved in a third hallmark of cancer: metastasis of cancer cells.
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Effects of Inflammation
Since inflammation is a type of immune response, persistent inflammation would signify
that immune cells are constantly being recruited to inflamed sites. This is problematic, as some
immune cells are able to be manipulated by mutated cells and contribute to the development of
cancer. While the immune system can reduce the incidence of cancer progression, some immune
cells and signals are associated with cancer. Tumor-associated macrophages (TAM) are
inflammatory cells that are components of most tumors, along with cytokines (small signaling
proteins) that act as colony-stimulating factors.⁹⁴ These cells in communion with one another can
allow tumors to persist in their survival and proliferate to keep themselves “alive.” Inflammatory
responses often involve these immune system components in amounts that are higher than
normal, which contributes to cancer cells’ signaling abilities as they proliferate.
Another type of immune cell, lymphocytes, can also contribute to cancer growth and the
development of metastatic qualities. Lymphocytes are white blood cells and are typically
responsible for killing foreign invaders or abnormal cells that they find.⁶⁴ However, some
lymphocytes, known as tumor-infiltrating lymphocytes, aid in the immunosuppression associated
with cancer metastasis. Normally, immune cells would recognize abnormal cells and attack them
to prevent their spread throughout the body. However, the lymphocytes activated in an
inflammatory environment act to block this recognition and suppress the normal immune
response.⁹⁴ This allows the cells to persist in their growth and proliferation until they break off
and move to other parts of the body through the blood through the process of metastasis.
Long-term inflammation also affects the immune system’s ability to identify and combat
cancer cells.⁷⁸ Since many tumors include inflammatory cytokines in its mass of cells, there is
some ability for them to recruit cells to suppress the action of the immune system and antagonize
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anti-tumor immune responses. The immune system can also be manipulated by the oncogenes
that aid in the progression and maintenance of cancerous tumors. Oncogenes in the RAS and
MYC families are expressed in CRC. These genes are involved in signaling pathways that can
recruit leukocytes and lymphocytes – both types of white blood cells – to induce a signaling
cascade and produce transcription factors, such as NF-κB, CREB, Ets-1, AP-1 and c-Myc. The
transcription factors can in turn lead to the remodeling of the tumor microenvironment using
endothelial cells to induce an angiogenic switch and begin recruiting the formation of new blood
vessels.⁷⁸ This stimulation of angiogenesis often occurs in an inflammatory environment, which
can also cause immunosuppression at distinct locations and provide a microenvironment for
pre-malignant cancer cells to thrive and accumulate oncogenic mutations. Eventually, this
sustained environment of inflammation promotes metastatic spread as well.⁷⁸
Studies carried out in recent years have shown that metastasis occurs through
communication between cancer cells and immune and inflammatory cells.⁷⁸ Inflammation can
aid in cancer metastasis for a number of reasons, the first being the ability of excess
inflammation to “hide” cancer cells from immune cells in the bloodstream. Malignant cells are
able to produce chemical signals that recruit platelets to help them break through the wall of a
blood vessel and “sneak” into the bloodstream.⁹⁵ Cancer cells are able to cloak themselves in
these recruited platelets to evade detection by immune cells present in the bloodstream. Once
cancer cells have left the bloodstream at a distant area of the body, they recruit the same platelets
to start the formation of new blood vessels through angiogenesis. This process uses growth
factors and chemical signaling that is induced by the presence of inflammation.⁹⁵ This supports
the idea that inflammation is involved in several aspects of cancer sustainment and movement
and works to promote cancer metastasis.
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Cancer Cell Metastasis
Metastasis is the process through which cancer cells migrate to other areas of the body
and establish new tumors. This process is what makes cancer so deadly, as they can cause a host
of problems, including organ failure, challenge in tumor removal and other treatments, and an
overall lack of control on the disease.⁹⁶ A depiction of this process is given in Figure 8 below.

Figure 8: The Process of Metastasis⁹⁷

Metastasis ultimately begins with angiogenesis. Factors within the tumor will signal for
this process to begin through a variety of mechanisms when the tumor begins to experience
stress and hypoxia. The recruitment and formation of new blood vessels allows some of the cells
on the fringes of the tumor to dissociate and invade through the wall of the blood vessel, thereby
allowing it entrance into the bloodstream and an escape from the original tumor mass.⁹⁵ Cancer
cells will travel through the blood until they are either identified and broken down by immune
cells or they become lodged in another area of the body and begin to proliferate, forming a new
tumor.²⁹ Since immune cells are present in ample amounts within the bloodstream, cancer cells
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risk being discovered and destroyed in their process of traveling to a new “ideal” environment,
but some inflammatory factors have been shown to play a role in the process of metastasis.
Ideally, metastasis will be avoided altogether through pathways of programmed cell death.

Metastasis of Colorectal Cancer
Metastasis is the major cause of death in patients who have CRC. The most common sites
of CRC metastasis are in the liver and the peritoneum, another name for the membrane lining the
abdominal cavity.⁹⁸ Patients whose CRC metastasizes to these sites are often in the later stages of
the disease, and these cases are very difficult to treat effectively. In addition to metastases to
these surrounding sites, up to 60% of patients are seen to develop metastases to additional tissues
within 5 years.⁹⁸ The location of CRC metastasis affects a patient’s prognosis and determines his
or her life expectancy, depending on where and how serious metastatic tumors are.
There are a number of different risk factors that determine how and where CRC will
metastasize to other areas of the body. One study showed that, of 34 risk factors associated with
metastasis that were investigated, only one showed concrete evidence as being linked to CRC
metastasis. This risk factor was identified as “vascular invasion for lymph node metastasis
[LNM] in pT1 CRC.⁹⁹” This means that when cancer cells invade outside of their boundaries and
into the lymphatic system, there is a high risk of a person experiencing cancer metastasis to
distant areas within his or her body. Though this study only noted one risk factor being
associated with metastasis, other papers have found different risk factors for metastasis to be
strongly linked as well.
Other risk factors for CRC metastasis are related to a patient’s body composition and
biological makeup. One study showed that people who are male and older in age showed greater
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susceptibility to CRC metastasis in some cases.¹⁰⁰ Additionally, a person’s tumor size and site,
along with his or her “histological growth pattern and mitotic rate” may also play a role in CRC
metastasis. The link between these factors and their mechanisms of action are still being
explored.¹⁰⁰ More research is needed to determine the concrete connection between these
potential risk factors and metastasis, however, understanding how specific factors influence a
person’s susceptibility to metastases can also offer better insight into treatment options that target
metastatic actions.

Treatments Targeting Metastasis
While many treatments for cancer target cell proliferation, some act by targeting
metastasis and preventing cancer’s spread throughout the body. One article detailed how
anti-inflammatory drugs such as Aspirin may be beneficial in combating cancer metastasis. Since
cancer cells are able to manipulate blood components and inflammatory properties within the
body to “hide” themselves from immune cells, the removal of these components should in turn
decrease the number of cancer cells that are able to evade immune recognition.⁹⁵ Aspirin is a
natural blood thinner, meaning that it alters the components of blood to decrease the amount of
platelets and clotting factors present. A reduction of platelets present in the blood would reduce a
cancer cell’s ability to “cloak” itself in these components and in turn reduce the number of cancer
cells that are able to escape the bloodstream and begin new tumor growths in distant areas of the
body.⁹⁵
Many of the developing treatment options targeting metastasis are cytostatic, rather than
cytotoxic, meaning that they function to inhibit cell growth or division rather than kill cells
completely.¹⁰¹ These kinds of medications may be more effective in targeting cancer cells
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specifically and decrease the number of severe side effects that are often caused by cytotoxicity.
Cytostatic drugs can disrupt cell signaling and replication without causing an immediate death of
cancer cells or a shrinking of a tumor’s size, though cytostatic activity will eventually lead to cell
death.¹⁰² Many of these drugs are still undergoing trials and preclinical experiments, so their
efficacy is not completely supported by every study, but these kinds of treatments prove
promising in the way of inflammation-induced metastasis. Perhaps the most influential way to
prevent metastasis induced by chronic inflammation would be to remove the factor of chronic
inflammation altogether.
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VII.

Discussion

Influence of Obesity on the Cancer Survival
Obesity influences the development of CRC through a variety of mechanisms, and
low-grade inflammation present in the bodies of obese individuals may be the most influential
aspect of obesity that leads to cancer. Though obesity and the consistent consumption of high-fat
diets have been shown to increase a person’s risk of cancer, it has also been shown to decrease a
person’s chance of survival or remission from cancer.¹⁰³ Despite any treatment of cancer that may
have occured, the microenvironment that allowed for the development of the disease initially is
still present if a person remains obese or continues to consume high levels of fat. This means that
though cancer may have been treated or even removed from the body fully, there is a greater
instance of recurrence, especially in previously affected areas of the body due to the persistence
of the ideal cancer microenvironment.
One study examined the effects of a person’s BMI and weight due to excess fat on his or
her likelihood of stage II and III rectal cancer recurrence. Their results showed that in men, obese
individuals were more likely to require an abdonimoperineal resection (APR,) a surgery in which
the anus, rectum, and parts of the colon are removed completely to remove any cancerous
tissue.¹⁰⁴ Obese men were also found to have a higher rate of local cancer recurrence after getting
an APR than lean men who received the same treatment. These results were not seen in women,
pointing to the fact that other factors besides excess fat on a person’s body alone are responsible
for cancer occurrence and recurrence in the context of obesity.¹⁰⁴ This supports the idea that other
factors, such as hormone signaling and specific innate immunity, are also involved in
determining a person’s colon cancer risk.
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A final piece of information gained from the same study was the knowledge that a
person’s weight was indicative of the toxicity (the extent to which a treatment is harmful or
poisonous) experienced due to adjuvant chemoradiotherapy.¹⁰⁴ As discussed previously,
individuals experience varied effects of cancer treatments, especially when given adjuvant
therapies. In this case, patients who were being treated for rectal cancer and had a higher BMI
were less likely to experience toxic effects of his or her cancer treatments than individuals who
had a lower BMI receiving the same drugs.¹⁰⁴ This points to the influence of a person’s specific
immune system and its response to outside influences such as drugs, as well as a person’s weight
and specific body composition playing a role in his or her specific treatment needs.

Current Treatments for CRC
Every person being treated for colon cancer requires his or her own specific plan of
attack based on the specific type of CRC and his or her body composition, as introduced above.
Despite this, there are trends in colon cancer treatments commonly used based on the
mechanisms they target or the effects they have. Treatments for CRC depend on a person’s type
or stage of CRC. Earlier stages of colon cancer are easier to treat completely with the surgical
removal of the affected parts of the colon and/or rectum.
If caught at an early stage, colon cancer polyps can be removed using a polypectomy or a
local excision. Both of these procedures involved the removal of polyps, or small tumors lining
the wall of the colon.¹⁰⁵ Local excisions are more complex, as they also include the removal of
some surrounding healthy tissue to ensure that the tumors have been removed completely.¹⁰⁵
Both of these procedures can be carried out laparoscopically, meaning that only a small incision
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is needed to access the area with a small camera and tools; this removes the need for the whole
abdomen to be cut open and decreases the risk for surgical complications.
Another surgical option for later stages of CRC are colectomies, which is the surgical
removal of all or part of the colon, along with nearby lymph nodes.¹⁰⁵ Later stages of colon
cancer are more likely to spread via the blood or lymph, so surrounding tissues that would aid in
their metastasis are often removed to prevent cancer development in other areas of the body.
These procedures can also be done laparoscopically in some cases, but total colectomies are
normally carried out using a single incision in the abdomen, to ensure that everything can be
reached.¹⁰⁵
In addition to surgical removal of colon or rectal cancers, adjuvant therapies are often
used to control the spread of cancer or reduce the risk of local occurrence. Adjuvant
chemotherapy is often used after surgery to kill any cancerous cells that may have been left
behind.¹⁰⁶ FOLFOX (folinic acid, fluorouracil, oxaliplatin) or XELOX (oxaliplatin, capecitabine;
also called CAPOX,) are the standard of care for many patients with stage III colon cancer; this
adjuvant chemotherapy regimen is used for 6 months for stage III colon cancer patients with
“good performance status.¹⁰⁷” However, these drugs have a high toxicity and can cause a variety
of undesirable symptoms. Using a drug with lower toxicity and the same efficacy over the same
time period or shortening the time period in which adjuvant therapy is given can lower these
effects.¹⁰⁷ Additionally, neoadjuvant therapies may be used before surgical procedures to shrink
tumors and attempt to make them easier to remove; these are often used in the case of rectal
cancers.¹⁰⁵
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Preventative Strategies for Colon Cancer
As introduced previously, preventative strategies are the most straightforward ways to
decrease cancer occurence and eliminate a need for any treatment, especially if certain risk
factors can be eliminated or avoided. This is true of CRC, as early screening for colon cancer has
been one of the most effective ways to decrease colon cancer instances in society. Colonoscopies
are one of the most commonly used preventative screening measures for colon cancer.¹⁰⁸ Their
aim is to detect abnormalities in colon tissues so that action can be taken before they progress
into malignant or metastatic cancers. Colonoscopies involve a long, flexible tube with a camera
on the end that is inserted into a person’s colon to see if there are any abnormalities that are
visible to the naked eye.¹⁰⁸ If any polyps, or small clumps of cells in the lining of the colon, are
present, they are often removed and tested via biopsy to see if any potentially harmful cells are
present.
This preventative strategy has been crucial in the catching and treating of colon cancer, as
it allows colon cancer to be detected at earlier stages and treated with greater chance of remission
or a complete cure. However, there is a need to identify and utilize additional preventative
strategies to decrease the instances of colon cancers further, and the place to focus may be on the
various factors that can lead to obesity.

Future Preventative Methods
While the link between high fat diets leading to obesity and colon cancer is not as direct
as some other cancer risk factors, there are many possible avenues to explore. One more obvious
way to decrease obesity is to decrease the consumption of high levels of unhealthy fats; it would
also be beneficial to couple this decrease in unhealthy consumption with an increase of physical
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activity daily. While this may seem an obvious solution, the issue of high fat diet consumption
often stretches far beyond personal lifestyle choices. There are dozens of factors that also
influence a person’s inclination to consume a high fat diet. Addressing these factors, both
separately and in relation to one another, may provide society a way to decrease both obesity and
the incidence of colon and other obesity-related cancers in the future.

Socioeconomic Status
A person’s socioeconomic status (SES) may be one of the most influential factors on his
or her diet and lifestyle. One study in particular found that there is a concrete link between a low
SES and increased numbers of obesity cases for a variety of reasons. The first of these is most
obviously a limited access to more nutritious foods and resources.¹⁰⁹ When a person has a lower
income, there is a certain level of concern for how one is to afford all of the basic necessities
needed for life. Groceries, especially healthier foods that are less processed and fresh produce
that may go bad easily, are often more expensive. For example, a study found that healthier food
options cost about $0.29 more per serving and $0.61-$2.51 per 2000 kcal than their less healthy
counterparts.¹¹⁰ This is due to the fact that healthier foods are not processed in the same ways as
unhealthier options and are often less easily accessible. Because of this, it is often easier for
individuals with a lower SES to afford foods that are less nutritious and more processed.¹⁰⁹
While access to healthier food options is often limited when a person has a lower SES,
incomplete knowledge of nutrition and health is an important factor influenced by SES.¹⁰⁹ In one
study, a group of adolescents from six Latin American cities were asked questions in five
categories pertaining to the fat and calorie content of foods and the relationship between obesity
and health. Of the 1272 students surveyed, those who came from wealthier backgrounds showed
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generally more knowledge in all five categories than those who came from lower SES groups.¹¹¹
This supports an overarching theory that people, especially children and adolescents with a lower
SES are generally less knowledgeable about unhealthy foods and their relationship to obesity.
They simply do not have the same resources and classroom instruction that people of higher SES
groups seemed to.¹¹¹
A final variable that is most likely influenced by a person’s SES is more limited physical
activity. This may be due to a lack of safe places to exercise or more deprived, unsafe
neighborhoods where physical activity may be hard to implement.¹⁰⁹ A study found that people
were less inclined to exercise or seek out physical activity if their neighborhoods were less safe
or pleasant.¹¹² This variable is also often found to be intertwined with that of a person’s race or
ethnicity. A lack of access to safe public gyms or parks is also influential in this issue.¹⁰⁹ This
idea as a factor that influences obesity may be difficult to address, as SES is hard to change
drastically over a short period of time; however, it would be worth the time and energy put into
remedying some of the strains on society that force a lower SES onto some people, as it is one of
the most influential factors for obesity.

Race and Ethnicity
A person’s race and ethnicity also plays a role on his or her susceptibility to developing
obesity, due to significant health disparities among racial groups. Between 2015 and 2017 in the
United States, the CDC noted that “non-Hispanic Black adults had the highest prevalence of
obesity (38.4%) overall, followed by Hispanic adults (32.6%) and non-Hispanic White adults
(28.6%)¹¹³” While genetic factors may play some role in these differences between racial groups,
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the biggest influences on different racial groups’ trends are that of the environmental, social, and
economic disadvantages experienced by some groups more than others.
Differences in health care and access to education are underlying risks that may add to
the disparities already experienced among racial groups. The disparities in educational levels in
2018 based on race and ethnicity are presented visually in the graph below (Figure 9):

Figure 9: Statistical Representation of Educational Achievement based on Race/Ethnicity¹¹⁴

These statistics show that Black and Hispanic populations had lower percentages than
White and Asian/Pacific Islander populations in both categories of educational attainment. This
supports the idea that a person’s race or ethnicity influences the opportunities and resources to
which they have access.¹¹⁴ Additionally, the increased prevalence in obesity within non-Hispanic
Black and the Hispanic populations can also be attributed to higher rates of unemployment, less
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access to high quality foods, fewer opportunities to practice regular physical activity, and less
access to quality health care.¹¹³
Race or ethnicity as a factor of obesity is strongly associated with one or more other
factors, which make it one of the most difficult to isolate and understand completely. In order to
address this factor as a risk factor for obesity, centuries of societal norms would have to be
reversed or remediated to reach equity and remove racial and ethnical disparities among
populations. This may be the most complex issue to address, as far as reducing it as a risk factor
for obesity goes; however, it may be one of the most impactful changes on obesity incidence and
society as a whole.

Environment
The idea of a person’s environment as a factor may not seem as influential as some of the
others that are causative of obesity, but its implications stretch deeper than they may seem. A
“toxic environment” has been persistent in the United States over the past decades that contribute
to the prevalence of obesity, such as super-sizing portions at restaurants, making fast foods more
accessible with new convenience restaurants popping up rapidly, and offering less nutritious
options in school cafeterias.¹⁰⁹ An ecological study showed that lower SES classes in Melbourne,
Australia had 2.5 times the access to fast food outlets than their higher SES counterparts,
supporting the idea that a person’s environment and the things to which they are exposed daily
are influential in their consumption of less nutritious foods on a consistent basis.¹⁰⁹
While the most obvious influences of the environment may be an increased accessibility
to high fat foods, environmental influences such as a decreased need for physical activity in the
workplace and reduced options for physical activity in schools for developing children can also
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play a part.¹⁰⁹ Society today generally seeks greater efficiency and ease of access in almost every
aspect of life, and these changes to society’s environment certainly meet this need. Improving
environments that are less ideal and play a role in increasing obesity occurrences in society as a
whole may help to alleviate some of its associated stress and weaken this factor’s link to obesity.

Biological Sex
A person’s biology is also an important factor in his or her likelihood of developing
obesity, and this factor is often difficult or impossible to change. Biological sex also plays a role
in a person’s body composition, such as bone mass density, hormone secretions (depending on
which sex organs are present,) and body fat deposition areas within the body.¹¹⁵ Each individual
is different in his or her specific body composition, but there are trends within each biological
sex that have been found and can point to a reason for some obesity cases.
The biggest difference between men and women that has a significant effect on his or her
ability to develop obesity is that of metabolism. It has been shown that women have evolved
specific mechanisms that favor the storage of fat in the process of metabolism, while men often
exhibit a more efficient burning and mobilization of fat.¹¹⁶ This may be due to the fact that
women have evolved a more efficient system of fat storage as was necessary throughout
evolution.¹¹⁷ The actual cause of this difference in metabolism is unknown, but there are some
indications that a person’s body size, muscle, and fat components have some effect on a person’s
metabolism.¹¹⁷
Additionally, the presence of different sex organs and, therefore, different sex hormones
can provide some influence on his or her ability to develop obesity. Women possess ovaries
producting the sex hormones estrogen and progesterone, while men possess testes producing
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testosterone. Both of these hormones decrease within women or men over time, and differing
levels of each hormone can influence the development of metabolic diseases or imbalances,
depending on his or her season of life.¹¹⁶ Women going through menopause have different
hormone levels than women who are still ovulating, and this difference plays a role in a women’s
metabolism efficiency. Possessing estrogen vs. testosterone can ultimately influence how
effective a person’s metabolism and energy burning/fat storage processes are.
Biological sex, as well as gender identity, are both factors that are difficult to study in
experimental settings and hard to generalize to a population. These aspects as influential factors
on obesity occurrence within society is still being explored, as the links between them are still
unclear.

Genetics
Genetic predisposition may be the most complex scientifically, as it deals with specific
differences in DNA sequence that predispose individuals to developing either obesity, cancer, or
both. Every person’s DNA sequence is unique, but by sequencing the DNA of an individual's
genome, trends within genomes can be uncovered. These trends can then be noted through
GWAS (a genome-wide association study,) which can examine loci, or specific areas on
chromosomes, for specific linkage and be used to identify the sequence’s predisposition.¹¹⁸ There
have been over 20 identified loci involved in obesity susceptibility, many of which are involved
in the regulation of food intake, such as in metabolism, and in the function of a person’s
adipocyte cells.¹¹⁷ Some genes that are associated with obesity when altered are SH2B1, FTO,
and PCSK1.¹¹⁸ The ways in which these genes influence obesity are concrete, but are complex
and will not be discussed in detail for the purposes of this thesis.
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Genetic factors may be some of the easiest to target of obesity-linked factors. If a gene’s
locus on a specific chromosome and its products (proteins or actions) are known, they can be
targeted with drugs to either increase or decrease their functions as required.¹¹⁷ The first FDA
approved drug to treat obesity associated with genetic conditions was approved in 2020. This
drug, known as Imcivree (setmelanotide,) works to provide chronic weight management, in the
form of “weight loss and weight maintenance for at least one year.¹¹⁹” This drug can only be used
in patients with one of three rare genetic conditions: pro-opiomelanocortin (POMC) deficiency,
proprotein subtilisin/kexin type 1 (PCSK1) deficiency, and leptin receptor (LEPR) deficiency, all
conditions characterized by severe obesity at a young age. Confirmation of these conditions
should be confirmed by genetic testing to determine that variants in POMC, PCSK1, or LEPR
genes are present and if they are considered pathogenic, in order for Imcivree to be prescribed.¹¹⁹
Scientists are always working to develop other treatments and preventative strategies for other
conditions associated with obesity in an attempt to prevent other comorbidities from occurring
alongside it.

Conclusion
In order to see the full effects of a decrease in high fat diet consumption, there would
need to be extensive studies over a number of years to compare the long-term effects of high fat
diets and healthier diets on the development of obesity-related cancers. This could include
studies in living organisms to compare the changes experienced in the microenvironment of
obese organisms vs. those retaining less body fat, as well as studies looking at the impact of
excess fat loss on an organism’s predisposition to colon cancer. Identifying a more concrete
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biological link between obesity and colon cancer would also be beneficial in the furthering of
this field of knowledge.
There will never be a “cure all” to decrease colon cancer risk. However, gaining a better
understanding of how external factors influence high fat diets and obesity as risk factors for
colon cancer could offer greater insight into what preventative measures are actually possible.
Each factor mentioned above adds to the multifaceted nature of obesity and high fat diets as risk
factors for cancers such as colon cancer. Because these factors are so intertwined and depend on
each others’ influence, it is hard to isolate a single aspect to target. These factors will not be
relieved easily during our lifetimes; however, intentional and persistent attempts to alleviate
some of these stressors for the greater society will be one of the first steps to increasing
preventative efforts to combat obesity-related cancers. Focusing on preventative strategies for
CRC and other obesity-related cancers could be an important shift in focus within the community
of cancer biology in the years to come.
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IX.

Glossary of Terms

Adaptive immunity: Also known as acquired immunity; produces and uses immune cells and
antibodies to combat foreign invaders as a form of immune response.
Adipokines: A type of cytokine produced by adipose tissue. These molecules play a role in
metabolism, inflammation, and other body processes.
Adiponectin: A protein, also a hormone and adipokine; regulates glucose levels in the blood and
the breakdown of fatty acids.
Adipose tissue: A kind of connective tissue composed of adipocyte (fat) cells
Amino acids: Organic molecules that comprise proteins; There are 20 different amino acids that
can combine in a variety of ways to form any possible protein.
Angiogenesis: The formation of new blood vessels. This is normally a process carefully
controlled by chemical signaling, but is often hijacked in cancer; it is one of cancer’s hallmarks
Antibiotic: A type of medicine that works to kill microorganisms such as bacteria
Antibody: A protein found in blood produced as a response to a foreign substance, known as an
antigen
Antigen: A foreign substance that causes an immune response, such as the production of
antibodies
Apoptosis: The process of programmed cell death; a normal and necessary process within the
body
Benign: growths or tumors that are not metastatic and stay in their original sites
B lymphocyte: A type of immune cell that produces antibodies

Braeuner 92
Carcinogen: Any cancer-causing agent. These agents can disrupt cellular processes or damage
cells’ genomes.
Chemotherapy: a type of cancer treatment that acts by killing cells or slowing their growth.
This treatment is often used alongside another treatment such as radiation to maximize its
effectiveness.
Chromosome: A long strand of DNA, which contains the genetic information of an organism
Chronic illness: Conditions that are long-lasting and require ongoing treatment to control
complications and associated symptoms
Cytokine: A type of protein involved in cell signaling, can be involved in inflammatory
responses
Disease: A harmful variation from a normal structural or functional state in an organism.
Diseases generally have certain signs and symptoms associated with them.
DNA damage: Occurs as a result of exposure to damaging agents. If DNA damage is left
unrepaired, it can result in DNA mutations.
DNA mutation: A change in a specific DNA sequence, often resulting from overwhelming
DNA damage that is left unrepaired; can also lead to changes in the products produced
EGF (epidermal growth factor): A kind of protein that signals for cell growth by binding to
EGFR, its receptor
Endocrine system: A body system containing organs and hormone products involved in
regulating biological processes
Epithelium: A thin tissue lining all internal and external surfaces of the body, including body
cavities and hollow organs; line the digestive tract from esophagus to rectum
Homeostasis: A body’s normal, balanced state
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Hormone: A type of signaling molecule that regulate physiology and behavior as a part of the
endocrine system; many have the ability to travel to distant tissues and organs through the
bloodstream
Immune cells: A part of the immune system, most commonly in the form of white blood cells.
Some examples are lymphocytes (T-cells, B-cells and NK cells), neutrophils, and
monocytes/macrophages.
Immunity: The ability of an organism to resist infections or other foreign substances through the
use of specific antibodies
Immunosuppressant: Something that suppresses the action of the immune system
Innate immunity: Also known as natural immunity; serves as a general method to recognize and
attack foreign invaders
Kinase: An enzyme that aids in the phosphorylation of specific molecules, usually found in a
signaling cascade
Leptin: A hormone secreted by adipocytes that regulates energy balance and fat storage
Leucocyte: A white blood cell; circulates in blood and lymph that work to combat foreign
invaders and substances
Malignant: A characteristic of a disease that usually means it leads to death. Malignant tumors
are cancerous and can spread to other areas of the body.
Metastasis: The action of cancer cells moving from their site of origin to other areas of the body
to proliferate; one of the hallmarks of cancer
Microenvironment: A specific, small-scale environment within the body’s tissues; a distinct
part of the larger body environment that can be influenced by a variety of factors to change its
composition
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Mitochondria: A organelle found in eukaryotic cells where cellular respiration occurs to
produce energy (in the form of ATP)
Obesity: A chronic condition involving excess body fat that can increase the risk of other health
issues
Oncogene: Any mutated gene associated with the development of cancer
Pathogen: A foreign substance such as a bacterium, virus, or microorganism that causes disease
Pathology: The study of disease
Proliferation: rapid production and growth of cells
Radical surgery: A type of cancer treatment meant to remove cancer entirely, often includes the
removal of cancerous tissue along with surrounding healthy tissue, muscle, and lymph nodes
Risk factor: Any condition or behavior that can expose a cell to carcinogenic factors, which lead
to the development of different forms of cancer
Tumor: An abnormal growth of tissue within the body. Tumors can be either benign or
malignant and are often formed in many kinds of cancer
Tumor suppressor gene: A gene that regulates cell division to keep cell growth under control. A
mutation in these genes often results in a loss or reduction of their abilities, which can aid in
cancer development
Vasculature: The network of blood vessels that make up the circulatory system which carry
blood from the heart to other tissues and organs within the body
VEGF (Vascular endothelial growth factor): A type of signal protein that can stimulate the
formation of new blood vessels through the activation of endothelial cells (EC)
White adipose tissue: Tissue made up of many different types of cells, such as adipocyte cells
that store fat, endothelial cells, blood cells, and others

